The following is an excerpt.
According to the World Health Organisation more than 55,000 people die after contracting rabies every year. Most of these deaths occurred in Asia and Africa, in areas where swift access to post-exposure vaccines is limited due to the high cost of manufacturer. “For at least three decades WHO has fought to break the “cycle of neglect” affecting rabies prevention and control particularly in low- and middle-income countries,” the international body states.
Work by the Hotung Molecular Immunology Unit could be one of the first steps to changing that, with its vision for fields of cheap, easily accessible antidotes.
Read the full article here: Genetically modified tobacco produces cheap, effective rabies treatment
